<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Joyce BT</submitter><funding>Intramural NIH HHS</funding><funding>NIA NIH HHS</funding><funding>American Heart Association-American Stroke Association</funding><funding>University of Alabama at Birmingham</funding><funding>NHLBI NIH HHS</funding><funding>Kaiser Foundation Research Institute</funding><funding>National Heart, Lung, and Blood Institute</funding><funding>University of Minnesota</funding><funding>Northwestern University</funding><funding>Intramural Research Program</funding><funding>National Institute on Aging</funding><pagination>2517-2523</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9799217</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>77(12)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Studies found associations between pulmonary function (PF) and cognition, but these are limited by mostly cross-sectional design and a single measure of PF (typically forced expiratory volume in 1 second [FEV1]). Our objective was to prospectively analyze the association of repeatedly measured PF with cognition.&lt;h4>Methods&lt;/h4>We studied 3 499 participants in the Coronary Artery Risk Development in Young Adults cohort with cognition measured at year 25 (Y25) and Y30, and PF (FEV1 and forced vital capacity [FVC], reflecting better PF) measured up to 6 times from Y0 to Y20. Cognition was measured via Stroop test, Rey-Auditory Verbal Learning Test [RAVLT], and digit symbol substitution test [DSST], which capture executive function, verbal learning and memory, and attention and psychomotor speed, respectively; lower Stroop, and higher RAVLT and DSST scores indicate better cognition. We modeled linear, cross-sectional associations between cognition and PF at Y30 (mean age 55), and mixed models to examine associations between cognition at Y25-Y30 and longitudinal PF (both annual rate of change, and cumulative PF from Y0 to Y20).&lt;h4>Results&lt;/h4>At Y30, FEV1 and FVC were cross-sectionally associated with all 3 measures of cognition (β = 0.08-0.12, p &lt; .01-.02). Annual change from peak FEV1/FVC ratio was associated with Stroop and DSST (β = 18.06, 95% CI = 7.71-28.40; β = 10.30, 95% CI = 0.26-20.34, respectively), but not RAVLT. Cumulative FEV1 and FVC were associated with Stroop and DSST (β = 0.07-0.12, p &lt; .01-.02), but only cumulative FEV1 was associated with RAVLT (β = 0.07, 95% CI = 0.00-0.14).&lt;h4>Conclusions&lt;/h4>We identified prospective associations between measures of PF and cognition even at middle ages, adding evidence of a prospective association between reduced PF and cognitive decline.</pubmed_abstract><journal>The journals of gerontology. Series A, Biological sciences and medical sciences</journal><pubmed_title>Pulmonary Function in Midlife as a Predictor of Later-Life Cognition: The Coronary Artery Risk Development in Adults (CARDIA) Study.</pubmed_title><pmcid>PMC9799217</pmcid><funding_grant_id>HHSN268201800005I</funding_grant_id><funding_grant_id>HHSN268201800004I</funding_grant_id><funding_grant_id>AG0005</funding_grant_id><funding_grant_id>HHSN268201800007I</funding_grant_id><funding_grant_id>HHSN268201800006I</funding_grant_id><funding_grant_id>HHSN268201800003I</funding_grant_id><funding_grant_id>19CDA34630050</funding_grant_id><funding_grant_id>R01 HL122477</funding_grant_id><pubmed_authors>Washko G</pubmed_authors><pubmed_authors>Zheng Y</pubmed_authors><pubmed_authors>Liu K</pubmed_authors><pubmed_authors>Gross M</pubmed_authors><pubmed_authors>Henkle BE</pubmed_authors><pubmed_authors>Kunisaki KM</pubmed_authors><pubmed_authors>Hou L</pubmed_authors><pubmed_authors>Thyagarajan B</pubmed_authors><pubmed_authors>Lloyd-Jones D</pubmed_authors><pubmed_authors>Yaffe K</pubmed_authors><pubmed_authors>Sidney S</pubmed_authors><pubmed_authors>Kalhan R</pubmed_authors><pubmed_authors>Joyce BT</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Jacobs DR</pubmed_authors><pubmed_authors>Gao T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Pulmonary Function in Midlife as a Predictor of Later-Life Cognition: The Coronary Artery Risk Development in Adults (CARDIA) Study.</name><description>&lt;h4>Background&lt;/h4>Studies found associations between pulmonary function (PF) and cognition, but these are limited by mostly cross-sectional design and a single measure of PF (typically forced expiratory volume in 1 second [FEV1]). Our objective was to prospectively analyze the association of repeatedly measured PF with cognition.&lt;h4>Methods&lt;/h4>We studied 3 499 participants in the Coronary Artery Risk Development in Young Adults cohort with cognition measured at year 25 (Y25) and Y30, and PF (FEV1 and forced vital capacity [FVC], reflecting better PF) measured up to 6 times from Y0 to Y20. Cognition was measured via Stroop test, Rey-Auditory Verbal Learning Test [RAVLT], and digit symbol substitution test [DSST], which capture executive function, verbal learning and memory, and attention and psychomotor speed, respectively; lower Stroop, and higher RAVLT and DSST scores indicate better cognition. We modeled linear, cross-sectional associations between cognition and PF at Y30 (mean age 55), and mixed models to examine associations between cognition at Y25-Y30 and longitudinal PF (both annual rate of change, and cumulative PF from Y0 to Y20).&lt;h4>Results&lt;/h4>At Y30, FEV1 and FVC were cross-sectionally associated with all 3 measures of cognition (β = 0.08-0.12, p &lt; .01-.02). Annual change from peak FEV1/FVC ratio was associated with Stroop and DSST (β = 18.06, 95% CI = 7.71-28.40; β = 10.30, 95% CI = 0.26-20.34, respectively), but not RAVLT. Cumulative FEV1 and FVC were associated with Stroop and DSST (β = 0.07-0.12, p &lt; .01-.02), but only cumulative FEV1 was associated with RAVLT (β = 0.07, 95% CI = 0.00-0.14).&lt;h4>Conclusions&lt;/h4>We identified prospective associations between measures of PF and cognition even at middle ages, adding evidence of a prospective association between reduced PF and cognitive decline.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-19T17:57:41.346Z</modification><creation>2025-04-19T17:57:41.346Z</creation></dates><accession>S-EPMC9799217</accession><cross_references><pubmed>35106576</pubmed><doi>10.1093/gerona/glac026</doi></cross_references></HashMap>